Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
2021 · Nature Communications · 87 citations
https://doi.org/10.1038/s41467-021-25997-3
Y
Ying Gu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
201
Papers
4.9K
Citations
38
h-index
100
i10-index
Ying Gu is an academic researcher from Xiamen University. The author has contributed to research in topics: Viral gastroenteritis research and epidemiology & Monoclonal and Polyclonal Antibodies Research & Hepatitis Viruses Studies and Epidemiology. The author has an h-index of 38, co-authored 171 publications.
ORCID: 0000-0002-2870-2800Papers by this author
worksIdentification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
2022 · Nature Communications · 43 citations
https://doi.org/10.1038/s41467-022-32926-5
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
2018 · Nature Communications · 38 citations
https://doi.org/10.1038/s41467-018-07199-6
Structure and proposed DNA delivery mechanism of a marine roseophage
2023 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-023-39220-y
Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
2021 · Microbial Cell Factories · 17 citations
https://doi.org/10.1186/s12934-021-01719-8
T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
2018 · Viruses · 14 citations
https://doi.org/10.3390/v10120667
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat